G2082 covers Spravato up to 56 mg and 2 hours of observation
Medicare's 2026 national physician rate is $952.59. Your note needs the dose, two blood pressures, the 2 hours, and the assessment before the patient leaves.
Head of Growth and Operations, JotPsych
Your patient took a 56 mg Spravato dose at 9:00 AM. You'll observe until at least 11:00 AM. Then you'll write the G2082 note.
Medicare's 2026 national rate for G2082 is $809.70 for a nurse practitioner, 85% of the physician rate.
Dose: 56 mg, 2 devices, self-administered at 9:00 AM under supervision.
Blood pressure before the dose: 128/82.
Blood pressure at 9:40 AM, about 40 minutes after the dose: 136/86.
Observed from the dose at 9:00 AM to 11:05 AM, with pulse oximetry; breathing unchanged.
11:05 AM: clinically stable and ready to leave.
[Clinician name, credentials, and signature]
The example note counts the 2 hours from the dose, as the G2082 descriptor does.
What each line of the example note shows
The Food and Drug Administration (FDA) label for Spravato, an esketamine nasal spray, sets each step of the visit. Take a blood pressure before the dose. Recheck the blood pressure at about 40 minutes. Monitor breathing, with pulse oximetry, for at least 2 hours after the dose.
End with the assessment. The label asks you to decide when your patient is "clinically stable and ready to leave."
When G2082 applies
The code covers any session with up to 56 mg, early in treatment or later. Its descriptor in a 2019 rule from the Centers for Medicare & Medicaid Services (CMS) includes "2 hours post-administration observation."
You can bill G2082 only when your practice supplies the drug, because under the same rule a provider who doesn't supply the drug "cannot report" G2082 for the visit. You'd bill an office visit instead.
You'd add 99415 once your clinical staff's observation runs 30 minutes past the visit's typical staff time. The typical staff time for a 99214 is 40 minutes. So 99415 starts at 70 minutes of your staff's time, and 99416, which covers each added 30 minutes, starts at 115.
For your own time, Medicare's code is G2212. You add G2212 to a 99215 billed by time once your total reaches 69 minutes, but you can't bill G2212 on the same date as 99415 or 99416.
What G2082's rate covers
CMS built G2082 from three parts: an office visit, clinical staff time for the 2 hours of observation, and the 56 mg of the drug itself. Medicare prices G2082 in relative value units.
Medicare's 2026 fee schedule puts 27.75 of G2082's 28.52 relative value units in practice expense. Most of the national physician rate of $952.59 pays for the drug and the staff who observe your patient.
Add the example note's lines to your G2082 template.
In Time on note & claim, enter the visit's start and duration, and JotPsych stamps both on the note.
Book 15 minutes- Centers for Medicare & Medicaid Services, PFS Relative Value Files: 2026 national physician rates and short descriptors (such as "Office o/p est mod 30 min") from the October 2026 release (RVU26D), file PPRRVU2026_Oct_nonQPP, conversion factor 33.4009.
- Legal Information Institute, Cornell Law School, 42 U.S.C. 1395l(a)(1)(N) and (O): Medicare pays 80 percent of the lesser of the actual charge and the fee schedule amount for a physician's service, and 80 percent of "the lesser of the actual charge or 85 percent of the fee schedule amount" for a nurse practitioner's, read October 2, 2026.
- U.S. Food and Drug Administration, SPRAVATO (esketamine) nasal spray prescribing information, revised April 2025, sections 2.1, 2.4, and 5.1.
- Centers for Medicare & Medicaid Services, Calendar Year 2020 Physician Fee Schedule final rule (CMS-1715-F), 84 FR 62568, November 15, 2019, pages 63103 to 63104.
- American Medical Association, CPT Evaluation and Management (E/M) Code and Guideline Changes, effective January 1, 2023: prolonged clinical staff services, 99415 and 99416, and the Reporting Prolonged Clinical Staff Time table.
- Centers for Medicare & Medicaid Services, Medicare Learning Network, Evaluation and Management Services (MLN006764), May 2026.